Monoclonal antibody therapies for solid tumors

Bevacizumab: A Treatment Option for Recurrent Glioblastoma Multiforme

(2008) Larry W Buie et al.   ANNALS OF PHARMACOTHERAPY

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

(2008) Anthony Gonçalves et al.   BMC CANCER

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma

(2008) Amani Asnacios et al.   CANCER

Advanced bladder cancer: Status of first-line chemotherapy and the search for active agents in the second-line setting

(2008) David J. Gallagher et al.   CANCER

Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies

(2008) Axel Grothey et al.   CANCER JOURNAL

Antibody-Drug Conjugates for Cancer Therapy

(2008) Paul J. Carter et al.   CANCER JOURNAL

A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer

(2008) Juan Lucas Bayo-Calero et al.   Clinical Breast Cancer

A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

(2008) S. J. Hotte et al.   CLINICAL CANCER RESEARCH

Correlation Between Rash and a Positive Drug Response Associated with Bevacizumab in a Patient with Advanced Colorectal Cancer

(2008) M. Wasif Saif et al.   Clinical Colorectal Cancer

Newer monoclonal antibodies for hematological malignancies

(2008) Jorge Castillo et al.   EXPERIMENTAL HEMATOLOGY

Tremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers

(2008) Ahmad A Tarhini et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Approved monoclonal antibodies for cancer therapy

(2008) Michael Boyiadzis et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Bevacizumab for the treatment of advanced non-small-cell lung cancer

(2008) Christian Manegold   Expert Review of Anticancer Therapy

Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer

(2008) Matthew D. Galsky et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

(2008) Nilofer S. Azad et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

(2008) Abby B. Siegel et al.   JOURNAL OF CLINICAL ONCOLOGY

VEGFPolymorphisms and Survival in Early-Stage Non–Small-Cell Lung Cancer

(2008) Rebecca Suk Heist et al.   JOURNAL OF CLINICAL ONCOLOGY

Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress

(2008) Robert K. Oldham et al.   JOURNAL OF CLINICAL ONCOLOGY

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

(2008) F. Anthony Greco et al.   LUNG CANCER

A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

(2008) David A. Reardon et al.   NEURO-ONCOLOGY

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab

(2007) Fernando Rivera et al.   ACTA ONCOLOGICA

Prodrug Strategies in Anticancer Chemotherapy

(2007) Felix Kratz et al.   ChemMedChem